Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025)
Alterity Therapeutics' (ATHE) quarterly Prepaid Assets came in at $512117.8 in Q4 2025, up 193.35% year-on-year from $174574.4 in Q4 2024, and down 90.89% quarter-over-quarter from $5.6 million in Q2 2025.
Alterity Therapeutics (ATHE) Prepaid Assets (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Prepaid Assets history runs 17 years deep, the most recent figure standing at $512117.8 for Q4 2025.
- On a quarterly basis, Prepaid Assets rose 193.35% year-over-year to $512117.8 in Q4 2025; TTM through Dec 2025 was $512117.8, a 193.35% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, down 100.0% from the prior year.
- Prepaid Assets eased to $512117.8 in Q4 2025 per ATHE's latest filing, from $5.6 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $469.9 billion in Q2 2022 and bottomed at $23563.0 in Q2 2024.
- The 5-year median for Prepaid Assets is $843191.8 (2022), against an average of $87.9 billion.
- Across the five-year window, Prepaid Assets surged 1851730310.47% in 2021 and sank 100.0% in 2023, its largest moves.
- Year by year, Prepaid Assets stood at $1.2 million in 2021, then tumbled by 55.32% to $520809.4 in 2022, then surged by 361.03% to $2.4 million in 2023, then sank by 92.73% to $174574.4 in 2024, then jumped by 193.35% to $512117.8 in 2025.
- Per Business Quant, the three latest ATHE Prepaid Assets figures stand at $512117.8 (Q4 2025), $5.6 million (Q2 2025), and $174574.4 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Alterity Therapeutics | 29.68 Bn | 29.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 512,117.76 |
| Jun 30, 2025 | 5.62 Mn |
| Dec 31, 2024 | 174,574.37 |
| Jun 30, 2024 | 23,563.00 |
| Dec 31, 2023 | 2.40 Mn |
| Jun 30, 2023 | 26,092.86 |
| Dec 31, 2022 | 520,809.36 |
| Jun 30, 2022 | 469.86 Bn |
| Dec 31, 2021 | 1.17 Mn |
| Jun 30, 2021 | 409.57 Bn |
| Dec 31, 2020 | 254,870.38 |
| Jun 30, 2020 | 22,118.48 |
| Dec 31, 2019 | 224,808.09 |
| Jun 30, 2019 | 314.35 Bn |
| Dec 31, 2018 | 135,950.23 |
| Jun 30, 2018 | 201,844.97 |
| Dec 31, 2017 | 300,146.52 |
| Jun 30, 2017 | 247.60 |
| Dec 31, 2016 | 107,128.62 |
| Jun 30, 2016 | 206.46 |